Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07661537 SHR-3079 B-Cell Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07661537 clinical trial report covering SHR-3079, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07661797 LNF2105 Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07661797 clinical trial report covering LNF2105, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
![NCT07660055 [177Lu]Lu-zolbetuximab HR-positive/HER2-low Breast Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook](https://synapse-static.patsnap.com/strapi-static/Blog_cover_14_36b6ffee12.jpg)
Latest Hotspot
8 min read
NCT07660055 [177Lu]Lu-zolbetuximab HR-positive/HER2-low Breast Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07660055 clinical trial report covering [177Lu]Lu-zolbetuximab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07661095 CRD-3874 Refractory acute myeloid leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07661095 clinical trial report covering CRD-3874, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07660341 CGB3002 Alzheimer Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07660341 clinical trial report covering CGB3002, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07661446 Dronabinol Opioid-Related Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07661446 clinical trial report covering Dronabinol, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07661420 211At-MABG Carcinoid Tumor Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07661420 clinical trial report covering 211At-MABG, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07660432 SIM-0689 Metastatic Solid Tumor Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07660432 clinical trial report covering SIM-0689, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262387 Human umbilical cord CD146 mesenchymal stem cells(Sanyoulikang) Ischemic stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262387 clinical trial report covering Human umbilical cord CD146 mesenchymal stem cells(Sanyoulikang), Phase 1, endpoints, sponsor, geography, readout
Latest Hotspot
8 min read
ChiCTR2600127046 KYS202004A Plaque psoriasis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
ChiCTR2600127046 clinical trial report covering KYS202004A, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07663838 GenSci142 Bacterial Vaginosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07663838 clinical trial report covering GenSci142, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07663032 PAN-X Salmonella Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07663032 clinical trial report covering PAN-X, Phase 1, endpoints, sponsor, geography, readout timing and development white space.